Higher Level of Mismatch in APOEε4 Carriers for Amyloid-Beta Peptide Alzheimer's Disease Biomarkers in Cerebrospinal Fluid.


Journal

ASN neuro
ISSN: 1759-0914
Titre abrégé: ASN Neuro
Pays: United States
ID NLM: 101507115

Informations de publication

Date de publication:
Historique:
entrez: 21 5 2019
pubmed: 21 5 2019
medline: 14 5 2020
Statut: ppublish

Résumé

Cerebrospinal fluid (CSF) biomarkers are widely used in the diagnosis of dementia. Even though there is a causal correlation between apolipoprotein E ( APOE) genotype and amyloid-beta (Aβ), the determination of APOE is currently not supported by national or international guidelines. We compared parallel measured CSF biomarkers of two independent laboratories from 126 patients who underwent clinical dementia diagnostics regarding the APOE genotype. APOE ε4 reduces Aβ1-42 (Aβ

Identifiants

pubmed: 31104469
doi: 10.1177/1759091419845524
pmc: PMC6535906
doi:

Substances chimiques

APP protein, human 0
Amyloid beta-Protein Precursor 0
ApoE protein, human 0
Apolipoproteins E 0
Biomarkers 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1759091419845524

Références

Alzheimers Dement. 2018 Jul;14(7):913-924
pubmed: 29601787
Med Clin North Am. 2013 May;97(3):363-8
pubmed: 23642575
Lancet Neurol. 2007 Aug;6(8):734-46
pubmed: 17616482
Mol Neurodegener. 2007 Apr 12;2:7
pubmed: 17430597
J Alzheimers Dis. 2018;62(1):203-212
pubmed: 29439341
Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):8098-102
pubmed: 8367470
Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1977-81
pubmed: 8446617
Alzheimers Dement. 2011 May;7(3):263-9
pubmed: 21514250
Alzheimers Dement. 2018 Apr;14(4):535-562
pubmed: 29653606
Alzheimers Dement. 2018 Nov;14(11):1470-1481
pubmed: 29499171
N Engl J Med. 1998 Feb 19;338(8):506-11
pubmed: 9468467
Neurosci Lett. 1992 Feb 3;135(2):235-8
pubmed: 1625800
Nat Rev Neurosci. 2008 Oct;9(10):768-78
pubmed: 18802446
Neurology. 2004 Jun 8;62(11):1977-83
pubmed: 15184600
J Neurosci Methods. 2009 Oct 15;183(2):238-40
pubmed: 19583979
J Alzheimers Dis. 2017;57(2):437-445
pubmed: 28269771
Neuron. 1995 Jul;15(1):219-28
pubmed: 7619525
Hum Mol Genet. 2012 Oct 15;21(20):4558-71
pubmed: 22821396

Auteurs

Jonathan Vogelgsang (J)

1 Department of Psychiatry and Psychotherapy, University Medical Center Goettingen, Georg-August-University, Germany.

Ruth Vukovich (R)

1 Department of Psychiatry and Psychotherapy, University Medical Center Goettingen, Georg-August-University, Germany.

Dirk Wedekind (D)

1 Department of Psychiatry and Psychotherapy, University Medical Center Goettingen, Georg-August-University, Germany.

Jens Wiltfang (J)

1 Department of Psychiatry and Psychotherapy, University Medical Center Goettingen, Georg-August-University, Germany.
2 German Center for Neurodegenerative Diseases, Goettingen, Germany.
3 iBiMED, Medical Science Department, University of Aveiro, Portugal.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH